Casein and Peptides Derived from Casein as Antileukaemic Agents
Autor: | Itzen Aguiñiga-Sánchez, Edgar Ledesma-Martínez, Benny Weiss-Steider, Ana Rocío Rivera-Martínez, Edelmiro Santiago-Osorio |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2019 |
Předmět: |
0301 basic medicine
business.industry medicine.drug_class Review Article medicine.disease_cause lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens lcsh:RC254-282 03 medical and health sciences Haematopoiesis 030104 developmental biology 0302 clinical medicine Immune system Oncology Biochemistry Opioid receptor 030220 oncology & carcinogenesis Casein Medicine Secretion Epigenetics Receptor business Oxidative stress |
Zdroj: | Journal of Oncology, Vol 2019 (2019) Journal of Oncology |
ISSN: | 1687-8469 1687-8450 |
Popis: | Milk is a heterogeneous lacteal secretion mixture of numerous components that exhibit a wide variety of chemical and functional activities. Casein, the main protein in milk, is composed ofα-,β-, andκ-caseins, each of which is important for nutritional value and for promoting the release of cytokines, also are linked to the regulation of haematopoiesis and immune response and inhibit the proliferation and induce the differentiation of leukaemia cells. It has been shown that the digestive process of caseins leads to the release of bioactive peptides that are involved in the regulation of blood pressure and the inhibition or activation of the immune response by serving as agonists or antagonists of opioid receptors, thus controlling the expression of genes that exert epigenetic control. Later, they bind to opioid receptor, block nuclear factorκ-beta, increase the redox potential, and reduce oxidative stress and the pro-inflammatory agents that favour an antioxidant and anti-inflammatory environment. Therefore, the bioactive peptides of casein could be compounds with antileukaemia potential. This review provides a summary of current knowledge about caseins and casein peptides on the immune system as well as their roles in the natural defence against the development of leukaemia and as relevant epigenetic regulators that can help eradicate leukaemia. |
Databáze: | OpenAIRE |
Externí odkaz: |